Study Examining the Effects of Mindfulness and Similar Audio-guided Exercises.

December 9, 2019 updated by: Canterbury Christ Church University

The Effects of Length of Mindfulness Practice on Mindfulness, Depression, Anxiety and Stress: A Randomised Controlled Experiment

This study aims to examine whether greater length of mindfulness practice results in more beneficial outcomes.

Study Overview

Detailed Description

This study will randomise participants to one of three groups: (1) four sessions of medium length mindfulness practice (lasting 20 mins) and 5 mins of an audio book; (2) four sessions of brief mindfulness practice (lasting 5 mins) and 20 mins of an audio book; and (3) a control group who just receive 4 sessions of audio book (lasting 25 mins). In the mindfulness arms, in each session, the participants will receive the audio book prior to the mindfulness practice. Mindfulness levels, and depression, anxiety and stress will be measured by self-report at baseline, session by session, and at post-intervention.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kent
      • Tunbridge Wells, Kent, United Kingdom, TN1 2YG
        • Canterbury Christ Church University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Members of the general public, especially university students or staff.
  • Adequate understanding of spoken and written English

Exclusion Criteria:

  • Currently experiencing significant difficulties with their mental wellbeing.
  • Currently have a personal mindfulness practice.
  • Currently participating in a mindfulness-based intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 20 minutes of mindfulness practice
Two sessions a week for two weeks of: 5 minutes listening to audio book excerpts followed by 20 minutes of audio guided mindfulness practice. Participants will be asked not to engage in formal mindfulness practice outside of these sessions during the study.
A 20 minute audio guided mindfulness of breathing practice per session, for four sessions.
5 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything') per session, for four sessions.
Active Comparator: 5 minutes of mindfulness practice
Two sessions a week for two weeks of: 20 minutes listening to audio book excerpts followed by 5 minutes of audio guided mindfulness practice. Participants will be asked not to engage in formal mindfulness practice outside of these sessions during the study.
A 5 minute audio guided mindfulness of breathing practice per session, for four sessions.
20 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything'), per session, for four sessions.
Placebo Comparator: Audio book control
Two sessions a week for two weeks of: 25 minutes listening to audio book excerpts (with non mindfulness practice). Participants will be asked not to engage in formal mindfulness practice during the study.
25 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything'), per session, for four sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline at post-intervention (week 3) on the Five Factor Mindfulness Questionnaire -15 item version (FFMQ-15)
Time Frame: Post-intervention (3 weeks after baseline).
The Five Factor Mindfulness Questionnaire -15 item version is a self-report measure of mindfulness, producing a total score between 15 and 75, with higher scores indicating greater levels of mindfulness. (Note that the observe subscale will be excluded from the calculation of the total score, as recommended in https://doi.org/10.1002/jclp.21865 and http://dx.doi.org/10.1037/pas0000263 producing a total score between 12 and 60).
Post-intervention (3 weeks after baseline).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline at post-intervention (week 3) on the Depression, Anxiety and Stress Scale - 21 item version (DASS-21).
Time Frame: Post-intervention (3 weeks after baseline).
The Depression, Anxiety and Stress Scale - 21 is a self-report measure of depression, anxiety and stress, producing a total score between 0 and 63, with higher scores indicating greater symptomatology.
Post-intervention (3 weeks after baseline).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sessional Five Factor Mindfulness Questionnaire -15 item version (FFMQ-15) scores.
Time Frame: Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3).
The FFMQ-15 (described above) will be administered at the start of the first session (baseline), immediately after sessions 2 (week 1), 3 (week 2) and 4 (week 2), and at post-intervention (week 3), to examine patterns in changes in mindfulness over the course of the study.
Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3).
Sessional Depression, Anxiety and Stress Scale - 21 item version (DASS-21) scores
Time Frame: Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3).
The DASS-21 (described above) will be administered at the start of the first session (baseline), immediately after sessions 2 (week 1), 3 (week 2) and 4 (week 2), and at post-intervention (week 3), to to examine patterns in changes over the course of the study.
Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3).
Session 1 Toronto Mindfulness Scale (TMS).
Time Frame: Session 1 (week 1).
The TMS is a 13-item self-report measure of state mindfulness that produces scores for curiosity and decentering. The curiosity score ranges from 0 to 24, the decentering score from 0 to 28, and the total score from 0 to 52, with higher scores indicating greater curiosity, decentering and overall state mindfulness respectively.
Session 1 (week 1).
Session 2 Toronto Mindfulness Scale (TMS).
Time Frame: Session 2 (week 1).
As described above.
Session 2 (week 1).
Session 3 Toronto Mindfulness Scale (TMS).
Time Frame: Session 3 (week 2).
As described above.
Session 3 (week 2).
Session 4 Toronto Mindfulness Scale (TMS).
Time Frame: Session 4 (week 2).
As described above.
Session 4 (week 2).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: James Cane, PhD, Canterbury Christ Church University
  • Principal Investigator: Sarah Strohmaier, MSc, Canterbury Christ Church University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2019

Primary Completion (Actual)

December 5, 2019

Study Completion (Actual)

December 5, 2019

Study Registration Dates

First Submitted

January 7, 2019

First Submitted That Met QC Criteria

January 7, 2019

First Posted (Actual)

January 9, 2019

Study Record Updates

Last Update Posted (Actual)

December 11, 2019

Last Update Submitted That Met QC Criteria

December 9, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • S_Strohmaier_29-11-18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mindfulness

Clinical Trials on 20 minutes of mindfulness practice

Subscribe